These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A gadolinium(III) complex with 8-amidequinoline based ligand as copper(II) ion responsive contrast agent. Li WS; Luo J; Chen ZN Dalton Trans; 2011 Jan; 40(2):484-8. PubMed ID: 21113542 [TBL] [Abstract][Full Text] [Related]
4. A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions. Livramento JB; Sour A; Borel A; Merbach AE; Tóth E Chemistry; 2006 Jan; 12(4):989-1003. PubMed ID: 16311990 [TBL] [Abstract][Full Text] [Related]
5. High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants. Gong P; Chen Z; Chen Y; Wang W; Wang X; Hu A Chem Commun (Camb); 2011 Apr; 47(14):4240-2. PubMed ID: 21359276 [TBL] [Abstract][Full Text] [Related]
6. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies. Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901 [TBL] [Abstract][Full Text] [Related]
7. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents. Shen C; New EJ Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598 [TBL] [Abstract][Full Text] [Related]
8. Novel polycarboxylated EDTA-type cyclodextrins as ligands for lanthanide binding: study of their luminescence, relaxivity properties of Gd(iii) complexes, and PM3 theoretical calculations. Maffeo D; Lampropoulou M; Fardis M; Lazarou YG; Mavridis IM; Mavridou DA; Urso E; Pratsinis H; Kletsas D; Yannakopoulou K Org Biomol Chem; 2010 Apr; 8(8):1910-21. PubMed ID: 20449498 [TBL] [Abstract][Full Text] [Related]
9. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging. Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217 [TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging. Laurent S; Vander Elst L; Wautier M; Galaup C; Muller RN; Picard C Bioorg Med Chem Lett; 2007 Nov; 17(22):6230-3. PubMed ID: 17889530 [TBL] [Abstract][Full Text] [Related]
11. Switchable MRI contrast agents based on morphological changes of pH-responsive polymers. Okada S; Mizukami S; Kikuchi K Bioorg Med Chem; 2012 Jan; 20(2):769-74. PubMed ID: 22206870 [TBL] [Abstract][Full Text] [Related]
12. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
13. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Caravan P Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145 [TBL] [Abstract][Full Text] [Related]
14. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of calcium responsive magnetic resonance imaging agent: Its relaxation and luminescence studies. Tanwar J; Datta A; Chauhan K; Kumaran SS; Tiwari AK; Kadiyala KG; Pal S; Thirumal M; Mishra AK Eur J Med Chem; 2014 Jul; 82():225-32. PubMed ID: 24904969 [TBL] [Abstract][Full Text] [Related]
16. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
17. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Xu J; Churchill DG; Botta M; Raymond KN Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797 [TBL] [Abstract][Full Text] [Related]
18. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Helm L Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173 [TBL] [Abstract][Full Text] [Related]
19. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics. Burai L; Tóth E; Sour A; Merbach AE Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439 [TBL] [Abstract][Full Text] [Related]
20. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging. Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]